Topic cluster
GLP-1 Pricing 2026: Insurance, Brand-Name, Compounded & Oral Options
Cost and access are the primary barriers to GLP-1 therapy for most patients. This cluster collects the pricing data, insurance audits, provider verification, and prescription pathway articles in one place — so you can answer 'what will this actually cost me' regardless of whether you're going through brand-name, compounded, or insurance-covered routes.
10 research articles in this cluster · last updated 2026-04-08
GLP-1 Compounded Pricing Index 2026
What 80+ telehealth providers actually charge for compounded semaglutide and tirzepatide — median, p10, p90, and how the gap to brand-name Wegovy has evolved.
Is $99 Compounded Semaglutide Real? We Verified Every Provider at the Floor Price
Multiple telehealth providers advertise compounded semaglutide at $99 per month — well below the market median. We verified the licensing, pharmacy partner, dose, and total monthly cost for each one.
How Compounded GLP-1 Prices Moved Over the Last 16 Months: Provider-by-Provider Trajectories
We tracked monthly cash prices for compounded semaglutide across the largest telehealth providers from January 2025 onward. Every provider in our tracked set has cut prices — but at very different rates, with the biggest movers converging on a $199 floor.
GLP-1 Insurance Coverage at the 10 Largest US Insurers: A 2026 Audit
Does your insurance cover Wegovy or Zepbound? We audited the 10 largest US health insurers — covering more than 460 million members combined — and the answer is the same everywhere: technically yes, but every plan requires prior authorization and coverage is plan-specific.
GLP-1 Insurance Coverage 2026: Medicare, Medicaid, Commercial, Tricare, VA, and FEHB Explained
What Medicare Part D, Medicaid, commercial insurance, Tricare, the VA, and FEHB actually covered for Wegovy, Zepbound, Ozempic, and Foundayo in 2026. Verified against CMS rules, the Medicare GLP-1 Bridge program, KFF/Mercer surveys, and the Trump administration's November 2025 deal with Novo Nordisk and Eli Lilly. With prior auth criteria, BMI thresholds, and what to ask your benefits administrator.
Where to Buy Foundayo (Orforglipron) in 2026: The Telehealth and Pharmacy Provider Directory
Foundayo (orforglipron) was FDA-approved April 1, 2026 and dispensing started April 6, 2026. Here is the verified list of US providers and pharmacies offering it as of April 2026: LillyDirect (manufacturer), Weight Watchers Med+, NowPatient, and the rollout we are tracking. Cash pay is $149-$299/month at the labeled doses; the Lilly Savings Card brings commercially-insured patients to $25/month.
Where to Buy Semaglutide in 2026: Verified US Provider List
The four legitimate US channels for semaglutide in 2026: brand Wegovy and Ozempic at major pharmacies, NovoCare Pharmacy direct-pay at $499/month, 503A compounded semaglutide via telehealth at $99-$249/month, and the insurance coverage path. Verified pricing from FDA labels, NovoCare, and our 80-provider dataset.
Where to Buy Tirzepatide in 2026: Verified US Provider List
The four legitimate US channels for tirzepatide in 2026: brand Zepbound via LillyDirect single-dose vials at $399-$499/month, Zepbound pen at retail pharmacy at $1,000-$1,300/month, Mounjaro for diabetes (off-label for weight loss), and 503A compounded tirzepatide via telehealth. Pricing verified from LillyDirect and our 80-provider dataset.
How to Get a GLP-1 Prescription in 2026: The Patient Buyer Funnel
Eight thousand patients a month search 'how to get semaglutide' or 'how to get tirzepatide.' This is the complete buyer funnel: insurance path (PBM step therapy and prior authorization), brand-name direct-pay (Wegovy NovoCare $199-$499, Zepbound LillyDirect $299-$449), compounded telehealth ($150-$400/mo), the new $25 oral Foundayo path, and the legitimacy red flags to watch for.
Wegovy Pen vs Compounded Vial: 12 Practical Differences Before You Switch
Brand-name Wegovy ships in a pre-filled multi-dose injector pen. Compounded semaglutide ships in a vial with a separate syringe. Same molecule, very different patient experience. We document every operational difference — refrigeration, dose math, needle gauges, injection technique — that matters when you're deciding between the two.